Current status of suture-mediated closure: What is the cost of comfort?

Journal of Vascular and Interventional Radiology

Volumn 14, Issue 6, 2003, Pages 677-681

  Brown, Daniel B ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD VESSEL INJURY; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DEVICE; FALSE ANEURYSM; HEALTH CARE COST; HIGH RISK PATIENT; HUMAN; INFECTIOUS COMPLICATION; INFLAMMATION; INTERVENTIONAL RADIOLOGY; MOBILIZATION; PATIENT SATISFACTION; PERCUTANEOUS CLOSURE DEVICE; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SUTURE; THROMBOSIS; WOUND CLOSURE;

EID: 0038510072     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RVI.0000079977.80153.80     Document Type: Review

References (40)

1. Wagner SC, Gonsalves CF, Eschelman DJ, Sullivan KL, Bonn J. Complications of a percutaneous suture-mediated device versus manual compression for arteriotomy closure: a case controlled study. J Vasc Interv Radiol 2003; 14:735-741.
2. Hofmann LV, Sood S, Liddell RP, et al. Arteriographic and pathologic evaluation of two suture mediated closure devices in a porcine model. J Vasc Interv Radiol 2003; 14:755-761.
3. Dowling K, Todd D, Siskin G, et al. Early ambulation after diagnostic angiography using 4-f catheters and sheaths: a feasibility study. J Endovasc Ther 2002; 9:618-621.
4. Baim DS, Knopf WD, Hinohara T, et al. Suture-mediated closure of the femoral access site after cardiac catheterization: results of the suture to ambulate and discharge (STAND I and STAND II) trials. Am J Cardiol 2000; 85:864-869.
5. Tommaso CL. Can the use of suture-mediated closure devices save the American health care system? Cathet Cardiovasc Intervent 2002; 57:303-304.
6. Eggebrecht, H, Haude M, Woertgen U, et al. Systematic use of a collagen-based vascular closure device immediately after cardiac catheterization procedures in 1,317 consecutive patients. Cathet Cardiovasc Intervent 2002; 57:486-495.
7. Schnyder G, Turi ZG. Complications of vascular closure devices -not yet evidence based. J Am Coll Cardiol 2002;39:1705-1706.
8. Rickli H, Unterweger M, Sutsch G, et al. Comparison of costs and safety of a suture-mediated closure device with conventional manual compression after coronary artery interventions. Cathet Cardiovasc Intervent 2002; 57:297-302.
9. Cherr GS, Travis JA, Ligush J. Infection is an unusual but serious complication of a femoral artery catheterization site closure device. Ann Vasc Surg 2001; 15:567-570.
10. Sprouse LR, Botta DM, Hamilton IN. The management of peripheral vascular complications associated with the use of percutaneous suture-mediated closure devices. J Vasc Surg 2001; 33:688-693.
11. Gonze MD, Sternberghill WC, Salartash K, Money SR. Complications associated with percutaneous closure devices. Am J Surg 1999; 178:209-211.
12. Nehler MR, Lawrence WA, Whitehill TA, Charatte SD, Jones DN, Krupski WC. Iatrogenic vascular injuries from percutaneous vascular suturing devices. J Vasc Surg 2001; 33:943-947.
13. Balzer JO, Scheinert D, Diebold T, Haufe M, Vogl TJ, Biamino G. Postinterventional transcutaneous suture of femoral artery access sites in patients with peripheral arterial occlusive disease: a study of 930 patients. Cathet Cardiovasc Intervent 2001; 53:174-181.
14. Duda SH, Wiskirchen J, Erb M. Suture-mediated percutaneous closure of antegrade femoral arterial access sites in patients who have received full anticoagulation therapy. Radiology 1999; 210:47-52.
15. Wetter DR, Rickli H, von Smekal A, Amann FW. Early sheath removal after coronary artery interventions with use of a suture-mediated closure device: clinical outcome and results of Doppler US evaluation. J Vasc Interv Radiol 2000; 11:1033-1037.
16. Gerckens U, Cattelaens N, Lampe EG, Grube E. Management of arterial puncture site after catheterization procedures: evaluating a suture-mediated closure device. Am J Cardiol 1999; 83:1658-1663.
17. Rinder MR, Tamirisa PK, Taniuchi M, Kurz HI, Mumm K, Lasala JM. Safety and efficacy of suture-mediated closure after percutaneous coronary interventions. Cathet Cardiovasc Intervent 2001; 54:146-151.
18. Kahn ZM, Kumar M, Hollander G, Frankel R. Safety and efficacy of the Perclose suture-mediated closure device after diagnostic and interventional catheterizations in a large consecutive population. Cathet Cardiovasc Intervent 2002; 55:8-13.
19. Fram DB, Giri S, Jamil G, et al. Suture closure of the femoral arteriotomy following invasive cardiac procedures: a detailed analysis of efficacy, complications, and the impact of early ambulation in 1,200 consecutive, unselected cases. Cathet Cardiovasc Intervent 2001; 53:163-173.
20. Todd DM, Hubner PJ, Hudson N, Sarma J, McCance AJ, Caplin J. Multicentre, prospective, randomized trial of 4 vs. 6 French catheters in 410 patients undergoing coronary angiography. Cathet Cardiovasc Intervent 2001; 54:269-275.
21. Siskin GP, Stainken BF, Dowling K, Meo P, Ahn J, Dolen EG. Outpatient uterine artery embolization for symptomatic uterine fibroids: experience in 49 patients. J Vasc Interv Radiol 2000; 11:305-311.
22. Singh H, Cardella JF, Cole PE, et al. Quality improvement guidelines for diagnostic arteriography. J Vasc Interv Radiol 2002; 13:1-6.
23. Di Mario C. Closure devices: case closed? Cathet Cardiovasc Intervent 2002; 55:14-15.
24. Dangas G, Mehran R, Kokolis S, et al. Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices. J Am Coll Cardiol 2001; 38:638-641.
25. Elek SD, Conen PE. The virulence of Staphylococcus Pyogenes for man: a study of the problems of wound infection. Br J Exp Pathol 1958; 38:573-586.
26. Katz S, Izhar M, Mirelman D. Bacterial adherence to surgical sutures: a possible factor in suture induced infection. Ann Surg 1981; 194:35-41.
27. Sharp WV, Belden TA, King PH, Teague PC. Suture resistance to infection. Surgery 1982; 91:61-63.
28. Weitz JI, Byrne J, Clagett GP, et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation 1996; 94:3026-3049.
29. Duffin DC, Muhlestein JB, Allisson SB, et al. Femoral arterial puncture management after percutaneous coronary procedures: a comparison of clinical outcomes and patient satisfaction between manual compression and two different vascular closure devices. J Invas Cardiol 2001; 13:354-362.
30. Brown DB, Crawford ST, Norton PL, Hovsepian DM. Angiographic follow-up after suture-mediated femoral artery closure. J Vasc Interv Radiol 2002; 13:677-680.
31. Nikolic B, Kessler CM, Ammann AM, et al. Hypercoagulability after uterine artery embolization for leiomyomata: does embolization predispose to a thromboembolic state (abstr.). J Vasc Interv Radiol 2003; 14(suppl):S5.
32. Mizuguchi A, Iwabuchi S, Moriyama N, et al. Effects on blood coagulation-fibrinolytic system after transcatheter hepatic arterial therapy in cases of hepatocellular carcinoma analyzed by plasma levels of plasmin-alpha 2-PI complex, D dimer and thrombin-ATIII complex. Nippon Shokakibyo Gakkai Zasshi 1990; 87:790-798.
33. Hoibraaten E, Qvigstad E, Arnesen H, Larsen S, Wickstrom E, Sandset PM. Increased risk of recurrent venous thromboembolism during hormone replacement therapy - results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET). Thromb Haemost 2000; 84:961-967.
34. Suissa S, Spitzer WO, Rainville B, Cusson J, Heinemann LL. Recurrent use of newer oral contraceptives and the risk of venous thromboembolism. Hum Reprod 2000; 15:817-821.
35. Weiss G. Risk of venous thromboembolism with third-generation oral contraceptives: a review. Am J Obstet Gynecol 1999; 180(2 part 2):295-301.
36. Vasilakis-Scaramozza C, Jick H. Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives. Lancet 2001; 358:1427-1429.
37. Danzi GB, Capuano C, Sesana M, et al. A randomised comparison of the use of 4 and 6 French diagnostic catheters: the limits of downsizing. Int J Cardiol 2001; 79:113-117.
38. Lefevre T, Morice MC, Bonan R, et al. Coronary angiography using 4 or 6 French diagnostic catheters: a prospective, randomized study. J Invas Cardiol 2001; 13:674-677.
39. Wheeldon NM. Coronary angiography using 4 French catheters. Int J Cardiol 2001; 80:5-6.
40. Miyamoto S, Ogawa H, Soejima H, et al. Enhanced platelet aggregation in the coronary circulation after coronary spasm. Thromb Res 2001; 103:377-386.